Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report

• Main Authors: Motoki Matsuura (Author), Kazuma Yorozu (Author), Sachiko Nagao (Author), Shoko Kurokawa (Author), Masato Tamate (Author), Taishi Akimoto (Author), Tsuyoshi Saito (Author)
• Format: Bog
• Udgivet: Elsevier, 2023-06-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Uterine leiomyosarcoma (LMS) is a gynecological malignancy with an extremely poor prognosis. Multiple new therapeutic agents, including pazopanib, trabectedin, and eribulin, have been clinically applied to treat uterine LMS, and their therapeutic effects are expected. We encountered one patient with...